Transcription factors as targets for cancer therapy.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 12360277.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A limited list of transcription factors are overactive in most human cancer cells, which makes them targets for the development of anticancer drugs. That they are the most direct and hopeful targets for treating cancer is proposed, and this is supported by the fact that there are many more human oncogenes in signalling pathways than there are oncogenic transcription factors. But how could specific transcription-factor activity be inhibited?
Medical subject headings
- Antineoplastic Agents
- Neoplasms
- Transcription Factors
- Zebrafish Proteins